Abstract
Hit finding strategy and discovery of molecular glues that drive CRBN-dependent ternary complex formation and selective degradation of HBS1L over GSPT1. A, Schematic of the parallel screening strategy used to identify HBS1L molecular glues. Left, HiBiT-based cellular assay using CRISPR knock-in of HiBiT at the endogenous HBS1L locus to enable high-throughput measurement of target degradation. Right, TR-FRET ternary complex assay to detect ligand-induced proximity between CRBN and HBS1L. Compounds active in both assays were prioritized. (Created in part with BioRender, Teng, T. (2026) https://BioRender.com/14wx5zd; Teng, T. (2026) https://BioRender.com/3lkesgf) B, Structures and activity summary for an initial screening hit TNG-6266 and optimized TNG961 in cellular degradation and ternary complex formation assays. AC50 is not reported when Bmax < 50%; DC50 and AC50 values are corrected for media binding. C, Compound profiling across the HBS1L-HiBiT degradation assay and the HBS1L ternary complex formation (induced proximity) assay. Color indicates the degree of selectivity for HBS1L over GSPT1 with DC50 values corrected for media binding. D, Activity summary for TNG-4857, TNG-7535, and TNG-7326; DC50 and AC50 values are corrected for media binding. E, Binding of TNG-4857 (yellow) at the interface of HBS1L (green) and CRBN (blue) in the 2.6 Å resolution cryo-EM structure of the HBS1L–CRBN–DDB1 complex (PDB 11MR). Dashed lines indicate hydrogen bonds.